Trial registration and publication

Don’t underestimate the extent of under-reporting

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f639 (Published 6 February 2013)
Cite this as: BMJ 2013;346:f639

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Carl Heneghan, director1,
  2. Matthew Thompson, clinical reader1
  1. 1Centre for Evidence-Based Medicine, University of Oxford, Oxford OX2 6GG, UK
  1. carl.heneghan{at}phc.ox.ac.uk

Chalmers and colleagues state that under-reporting of research “leads to overestimates of the benefits of treatments and underestimates of their harmful effects.”1

The extent of the problem should not be underestimated. A 2010 study of 546 drug trials, conducted between 2000 and 2006, reported …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL